COVID-19 and multiple sclerosis: A description of two cases on alemtuzumab.
Mult Scler Relat Disord
; 45: 102402, 2020 Oct.
Article
in En
| MEDLINE
| ID: mdl-32711297
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Immunocompromised Host
/
Coronavirus Infections
/
Multiple Sclerosis, Relapsing-Remitting
/
Alemtuzumab
/
Antineoplastic Agents, Immunological
Type of study:
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
Mult Scler Relat Disord
Year:
2020
Document type:
Article